IPP Bureau
Aster DM Healthcare signs MoU with Tamil Nadu govt to invest Rs. 500 crore
By IPP Bureau - March 27, 2022
The MoU proposed investments in hospitals, pharmacies and laboratories in the state
NMPA approves Hansizhuang, its first monoclonal antibody
By IPP Bureau - March 27, 2022
It also empowers domestic precision immunotherapy for tumours and promotes the high-quality development of China's biopharmaceutical industry
ScienceMedia and Apex Mobile Clinical Research sign partnership for clinical trial training
By IPP Bureau - March 27, 2022
The implementation of ScienceMedia's solutions will ultimately help AMCR collapse patient recruitment and enrollment
NATHEALTH 8th annual summit in New Delhi from March 28-29.
By IPP Bureau - March 26, 2022
More than 120 speakers and 5,000 delegates are expected to attend
RCSE partner with Rela Hospitals for advanced surgical course
By IPP Bureau - March 26, 2022
These courses are for pre-selected candidates who have completed their MBBS with an additional 2 years of surgical experience training
Confluent Medical Technologies to set up facility in Hyderabad
By IPP Bureau - March 26, 2022
Arizona-based, leading medical devices company, Confluent Medical Technologies, will be establishing a pilot manufacturing facility in Hyderabad.
Novavax to participate in two booster studies using its COVID-19 vaccine
By IPP Bureau - March 26, 2022
U.S. NIAID-sponsored trial will evaluate heterologous booster regimens, including NVX-CoV2373, after primary series with current USFDA approved or emergency use authorized-vaccines
Fujifilm India unveils new range of CT, MRI and ultrasound machines
By IPP Bureau - March 26, 2022
The enhanced portfolio includes the Scenaria View, Supria series, The Echelon Smart and Arietta series
Evusheld recommended for market authorisation in EU
By IPP Bureau - March 25, 2022
Recommendation based on Phase III PROVENT trial showing a significant reduction in the risk of developing symptomatic COVID-19, with protection lasting at least six months
Leadership changes at MedGenome
By IPP Bureau - March 25, 2022
Co–Founder Sam Santhosh steps down as Chairman and Group CEO; will remain on Board of Directors. Co–founder Mahesh Pratapneni appointed Group CEO. Dr. Felix Olale appointed Chairman of the Board
Aquavit Files IND with USFDA for DTX-021, a new botulinum toxin
By IPP Bureau - March 25, 2022
Aquavit will officially unveil the Dermatox and Microtox programs at the Annual American Academy of Dermatology, the world's largest dermatology conference scheduled from March 25-29, 2022, in Boston, MA
USFDA approves Janssen’s injectable regimen for HIV
By IPP Bureau - March 25, 2022
Cabenuva was co-developed as part of a collaboration with ViiV Healthcare and builds on Janssen's decades-long commitment to combatting HIV
Parata Systems earns HITRUST certification
By IPP Bureau - March 25, 2022
It recognizes the company's commitment to safeguarding sensitive data, protecting patient information
Medtronic announces first patient implants for bladder incontinence
By IPP Bureau - March 25, 2022
Titan 2 pivotal study to evaluate implantable tibial neuromodulation (TNM) device to help expand patient access to advanced therapy
Roche to present data across neuroscience portfolio at 2022 AAN Annual Meeting
By IPP Bureau - March 25, 2022
Additional data across neurological disorders, including Alzheimer’s disease, help advance the scientific understanding of these conditions and the potential impact of early treatment
